Log In
BCIQ
Print this Print this
 

YH4808

  Manage Alerts
Collapse Summary General Information
Company Yuhan Corp.
DescriptionPotassium competitive acid blocker
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationGastroesophageal reflux disease (GERD)
Indication DetailsTreat gastroesophageal reflux disease (GERD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today